1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 31
2.4 Emerging Opportunities and Market Trends 34
2.5 Porters Fiver Forces Analysis 38
3 Segmentation of Asia Pacific Market by Product 43
3.1 Market Overview by Product 43
3.2 Kits & Assays 45
3.3 Analyzers & Instruments 46
3.4 Software & Services 47
4 Segmentation of Asia Pacific Market by Technology 48
4.1 Market Overview by Technology 48
4.2 Polymerase Chain Reaction (PCR) 50
4.2.1 Real-Time PCR (rt-PCR) 51
4.2.2 Digital PCR (d-PCR) 52
4.3 Isothermal Nucleic Acid Amplification Technology (INAAT) 53
4.4 Genetic Sequencing-based Technology 54
4.5 Microarray-based Technology 55
4.6 Other Technologies 56
5 Segmentation of Asia Pacific Market by Application 57
5.1 Market Overview by Application 57
5.2 Infectious Disease 59
5.2.1 Respiratory Infections 61
5.2.2 Hospital Acquired Infections 62
5.2.3 Sexually Transmitted Infections 63
5.3 Gastrointestinal Infections 64
5.4 Oncology 65
5.5 Hepatitis 66
5.6 Prenatal/Neonatal Testing 67
5.7 Other Applications 68
6 Segmentation of Asia Pacific Market by End User 69
6.1 Market Overview by End User 69
6.2 Hospitals 71
6.3 Clinics & Diagnostic Centers 72
6.4 Research and Academic Institutes 73
6.5 Other End Users 74
7 Asia-Pacific Market 2019-2030 by Country 76
7.1 Overview of Asia-Pacific Market 76
7.2 Japan 79
7.3 China 82
7.4 Australia 85
7.5 India 87
7.6 South Korea 89
7.7 Rest of APAC Region 91
8 Competitive Landscape 93
8.1 Overview of Key Vendors 93
8.2 New Product Launch, Partnership, Investment, and M&A 97
8.3 Company Profiles 98
Abacus Diagnostica Oy 98
Abbott Laboratories 100
Alere Inc. 101
Biocartis Group NV 102
Biomerieux SA 103
Bio-Rad Laboratories Inc 104
Danaher Corporation 105
DiaSorin S.p.A 106
DxNA LLC. 107
F. Hoffmann-La Roche Ltd. 108
Hologic, Inc. 109
Luminex Corporation 110
Meridian Bioscience Inc. 111
Mesa Biotech Inc. 112
QIAGEN N.V. 113
QuantuMDx Group Ltd. 114
Quidel Corporation 115
Spartan Biosciences Inc. 116
Thermo Fisher Scientific 117
9 Investing in Asia Pacific Market: Risk Assessment and Management 118
9.1 Risk Evaluation of Asia Pacific Market 118
9.2 Critical Success Factors (CSFs) 121
Related Reports and Products 124